3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Neoplasm Metastasis
2
Melanoma
2
Esophageal Squamous Cell Carcinoma
2
Advanced Solid Tumour
2
Advanced Solid Tumor
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Simpson-Golabi-Behmel syndrome
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasm, Residual
1
Nasopharyngeal Carcinoma
1
Metastatic Solid Tumors
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Advanced Solid Tumors
1
Advanced Malignancies
1
Adenocarcinoma Of Esophagus
1
Interventions
Specimen Handling
7
Cisplatin
7
pembrolizumab
6
Nivolumab
4
Magnetic Resonance Spectroscopy
4
Human Papillomavirus DNA Tests
4
Fulvestrant
4
Colposcopy
4
Paclitaxel
3
Carboplatin
3
Bevacizumab
3
palbociclib
2
lenvatinib
2
Surveys and Questionnaires
2
Radiotherapy, Intensity-Modulated
2
Radiation Dose Hypofractionation
2
Radiation
2
Platinum
2
Magnetic Resonance Imaging
2
Gemcitabine
2
Fluorodeoxyglucose F18
2
Drug Therapy
2
Congresses as Topic
2
Brachytherapy
2
Biopsy
2
Axitinib
2
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
2
1,2-diaminocyclohexaneplatinum II citrate
2
ulixertinib
1
trastuzumab deruxtecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
tislelizumab
×
30 days
×
Clear all
No trials found.